Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pediatric Neurology · Early-Onset Dystonia and Hereditary Spastic Paraplegia

What It Is and What It Isn't: Biology and Look-Alikes

At a Glance

Childhood stiffness and toe-walking can result from spasticity, dystonia, cerebral palsy, hereditary spastic paraplegia, or treatable metabolic disorders. Progression, physical exams, MRI, family history, and targeted tests help doctors identify the cause.

To provide the best care for your child, it is helpful to understand exactly what is happening in their body. While the outward symptoms—stiff legs, walking on toes, or unusual postures—can look similar, the underlying biology often tells a different story.

Movement disorders in children generally fall into several categories: acquired (caused by an external event like a birth injury), genetic (caused by a change in the child’s DNA), metabolic, structural, immune, or idiopathic (unknown) [1]. Distinguishing between these is essential because they may require different treatments and follow a different timeline.

The Biology of Movement: Spasticity vs. Dystonia

Medical teams often use the terms spasticity and dystonia to describe how a child moves. While they both involve muscle stiffness, they are caused by different issues in the nervous system. Note that these are simplified explanations, and both are network disorders that often coexist.

Spasticity: An Upper Motor Neuron Sign

Spasticity is a clinical sign of upper-motor-neuron dysfunction, often caused by damage or degeneration in the corticospinal tract, the long nerves that carry movement signals from the brain down the spinal cord to the muscles [2].

  • The Mechanism: In Hereditary Spastic Paraplegia (HSP), the long nerves slowly break down over time [3]. This causes abnormal reflex modulation.
  • The Sign: Spasticity is velocity-dependent, meaning the muscle resists more the faster a doctor tries to move it [4]. Common signs include clonus (rhythmic shaking when the foot is pushed up) and very brisk reflexes [5].

Dystonia: A Network Coordination Issue

Dystonia is a disorder of a distributed motor network, often involving a region called the basal ganglia, affecting how the brain coordinates movement [4].

  • The Mechanism: The brain sends the wrong signals at the wrong time, causing muscles to contract when they should be resting.
  • The Sign: Dystonia causes involuntary, patterned twisting or repetitive movements [4]. Unlike spasticity, it is not velocity-dependent. It often fluctuates based on the child’s emotions, stress, or the specific task they are trying to do [6].

The “Look-Alikes”: What Else Could It Be?

Because these symptoms overlap, several conditions are frequently confused with one another.

Cerebral Palsy (CP)

Cerebral Palsy is the most common “look-alike.” CP is a clinical syndrome caused by a non-progressive disturbance in the developing brain, often without a documented birth injury [1].

  • The Clue: Periventricular leukomalacia is one possible MRI pattern for CP, but its absence does not establish HSP or another genetic disorder. However, if a child’s function and neurologic manifestations are progressively worsening, doctors should look closer for a genetic or metabolic cause [7][8].

Arginase-1 Deficiency

This is a rare but critical metabolic disorder. It can look exactly like spastic paraplegia, causing progressive leg stiffness and developmental delays [9].

  • Why It Matters: Unlike many other genetic conditions, Arginase-1 deficiency is treatable with a specific diet and medication [10]. Diagnosis requires appropriate plasma amino-acid and metabolic evaluation interpreted by a specialist, often with molecular confirmation; a single normal blood result should not be presented as excluding all cases [9].

Dopa-Responsive Dystonia (DRD)

This condition often starts in childhood with “toe-walking” or a “clumsy” gait that gets worse throughout the day [11].

  • The Clue: It can be misdiagnosed as CP or HSP, but a levodopa response can be supportive (though not by itself diagnostic) when properly prescribed and monitored by a clinician [12][13].

How Doctors Tell the Difference

Your care team uses a combination of history, physical exams, and imaging to evaluate these conditions.

Feature Cerebral Palsy Genetic/Metabolic Disorders
Birth History Often includes prematurity or oxygen loss, but not always [1]. Usually an uneventful pregnancy and birth [14].
Progression The underlying brain disturbance is non-progressive [7]. Symptoms may be progressive, slowly worsening over years [2].
MRI Findings May show specific scars like periventricular leukomalacia, but can be normal [8]. May be normal, or show specific signs like a thin corpus callosum [15][16].
Family History Usually no other family members are affected. May be a history of walking issues, though family history can be absent in recessive or de novo disease [17].

If your child’s symptoms are changing—such as losing the ability to walk, developing new seizures, or showing a decline in speech—it is a strong signal that the condition requires a genetic or metabolic evaluation [16][18].

Common questions in this guide

How are spasticity and dystonia different in a child?
Spasticity makes a limb resist more when it is moved quickly and may cause clonus, a rhythmic shaking, or unusually brisk reflexes. Dystonia causes patterned twisting or repeated muscle contractions that may change with stress, emotions, or a task. A child can have both, so the examination must assess each movement pattern.
Can cerebral palsy be confused with hereditary spastic paraplegia?
Yes. Cerebral palsy results from a non-progressive disturbance in the developing brain, while hereditary spastic paraplegia can cause gradually worsening stiffness and walking problems. Birth history, MRI, family history, and changes over time help guide evaluation, but no single clue proves the diagnosis.
When should a child with stiffness be evaluated for a genetic or metabolic disorder?
Progressive worsening, loss of walking ability, new seizures, or decline in speech, coordination, or bladder control should prompt a clinician to consider genetic or metabolic testing. An uneventful birth, a normal MRI, or no affected relatives does not rule out these conditions. The appropriate evaluation depends on the child’s examination and history.
What is arginase-1 deficiency, and can it be treated?
Arginase-1 deficiency is a rare metabolic condition that can resemble spastic paraplegia and cause progressive leg stiffness or developmental delays. It may be treatable with a specific diet and medication. Diagnosis usually involves specialist blood amino-acid and metabolic testing and sometimes molecular confirmation; one normal blood result does not exclude every case.
Could toe-walking be a sign of dopa-responsive dystonia?
Yes. Dopa-responsive dystonia can begin in childhood with toe-walking or a clumsy gait that worsens as the day goes on, and it can resemble cerebral palsy or hereditary spastic paraplegia. A response to levodopa can support the diagnosis but is not conclusive by itself, so any medication trial should be prescribed and monitored by a clinician.

Get notified when new evidence is published on dystonia, early-onset, and/or spastic paraplegia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Cerebral palsy.

    Graham HK, Rosenbaum P, Paneth N, et al.

    Nature reviews. Disease primers 2016; (2()):15082 doi:10.1038/nrdp.2015.82.

    PMID: 27188686
  2. 2

    Hereditary spastic paraplegia: a practical approach.

    Bradley M, Kalfat A, Walsh RA, et al.

    Practical neurology 2026; doi:10.1136/pn-2026-005344.

    PMID: 42816178
  3. 3

    Hereditary spastic paraplegia: More than an upper motor neuron disease.

    Parodi L, Fenu S, Stevanin G, Durr A

    Revue neurologique 2017; (173(5)):352-360 doi:10.1016/j.neurol.2017.03.034.

    PMID: 28449883
  4. 4

    Evolving understanding of CP phenotypes: the importance of dystonia.

    Lewis SA, Aravamuthan B, Fehlings D, Kruer MC

    Pediatric research 2024; doi:10.1038/s41390-024-03327-9.

    PMID: 38926549
  5. 5

    Early onset disease, anarthria, areflexia, and dystonia can be the distinctive features of SPG64, a very rare form of hereditary spastic paraplegias.

    Ölmez A, Çetin GO, Karaer K

    American journal of medical genetics. Part A 2022; (188(9)):2712-2717 doi:10.1002/ajmg.a.62878.

    PMID: 35758610
  6. 6

    Phenotypic insights into ADCY5-associated disease.

    Chang FC, Westenberger A, Dale RC, et al.

    Movement disorders : official journal of the Movement Disorder Society 2016; (31(7)):1033-40 doi:10.1002/mds.26598.

    PMID: 27061943
  7. 7

    Hereditary spastic paraplegia initially diagnosed as cerebral palsy.

    Suchowersky O, Ashtiani S, Au PB, et al.

    Clinical parkinsonism & related disorders 2021; (5()):100114 doi:10.1016/j.prdoa.2021.100114.

    PMID: 34816117
  8. 8

    Variability in Cerebral Palsy Diagnosis.

    Aravamuthan BR, Fehlings D, Shetty S, et al.

    Pediatrics 2021; (147(2)) doi:10.1542/peds.2020-010066.

    PMID: 33402528
  9. 9

    Arginase 1 Deficiency in Patients Initially Diagnosed with Hereditary Spastic Paraplegia.

    McNutt MC, Foreman N, Gotway G

    Movement disorders clinical practice 2023; (10(1)):109-114 doi:10.1002/mdc3.13612.

    PMID: 36698992
  10. 10

    Arginase 1 deficiency presenting as complicated hereditary spastic paraplegia.

    Freua F, Almeida MEC, Nóbrega PR, et al.

    Cold Spring Harbor molecular case studies 2022; doi:10.1101/mcs.a006232.

    PMID: 36180229
  11. 11

    Clinical and Basic Research on Dopa-Responsive Dystonia: Neuropathological and Neurochemical Findings.

    Furukawa Y

    Juntendo medical journal 2025; (71(1)):2-10 doi:10.14789/ejmj.JMJ24-0023-R.

    PMID: 40109402
  12. 12

    Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.

    Zhang W, Zhou Z, Li X, et al.

    Neuroscience letters 2017; (644()):48-54 doi:10.1016/j.neulet.2017.01.019.

    PMID: 28087438
  13. 13

    GCH1 mutations in hereditary spastic paraplegia.

    Varghaei P, Yoon G, Estiar MA, et al.

    Clinical genetics 2021; (100(1)):51-58 doi:10.1111/cge.13955.

    PMID: 33713342
  14. 14

    Monogenic variants in dystonia: an exome-wide sequencing study.

    Zech M, Jech R, Boesch S, et al.

    The Lancet. Neurology 2020; (19(11)):908-918 doi:10.1016/S1474-4422(20)30312-4.

    PMID: 33098801
  15. 15

    Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.

    Ebrahimi-Fakhari D, Alecu JE, Ziegler M, et al.

    Neurology 2021; (97(19)):e1942-e1954 doi:10.1212/WNL.0000000000012836.

    PMID: 34544818
  16. 16

    The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15.

    Saffari A, Kellner M, Jordan C, et al.

    Brain : a journal of neurology 2023; (146(5)):2003-2015 doi:10.1093/brain/awac391.

    PMID: 36315648
  17. 17

    MECP2 duplication syndrome initially misdiagnosed as cerebral palsy: a case report.

    Kim TY, Lee SJ, Kim KM, Cho SR

    The Journal of international medical research 2023; (51(3)):3000605231162452 doi:10.1177/03000605231162452.

    PMID: 36988314
  18. 18

    Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.

    Ebrahimi-Fakhari D, Teinert J, Behne R, et al.

    Brain : a journal of neurology 2020; (143(10)):2929-2944 doi:10.1093/brain/awz307.

    PMID: 32979048

This page is for informational purposes only and does not constitute medical advice. Your child’s pediatric neurologist or genetics or metabolic specialist should interpret symptoms and test results for your child.